Tech billionaire Elon Musk joined researchers to track COVID-19 infections and antibody levels in 4,300 SpaceX employees for a study published Feb. 15 in Nature Communications.
SpaceX’s medical executives teamed up with doctors and researchers to launch an antibody testing program last year. SpaceX employees who volunteered to participate in the study underwent monthly blood tests from mid-April to June 2020, reports The Wall Street Journal.
Of the 4,300 Spacex volunteers tested, 300 contracted COVID-19. Researchers had enough data on 120 workers to examine their antibody levels and draw conclusions for the study.
Researchers found that these workers had levels of antibodies that could provide immunity, but “the exact levels.” […] associated with protection against reinfection remain unclear. “
The study also found that antibodies were much lower in those who had milder symptoms.
The median age of the study participants was 31 and 92 percent were male. The authors said this could affect their results, as different ages generate different immune responses.
Click here for more information.
More articles on healthcare IT:
How health systems can use technology to succeed in value-based care
Cedars-Sinai adds 7 health technology startups to innovation accelerator
IBM is considering selling IBM Watson Health: 5 notes
© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING or REPRINTING this content? View our policies by clicking here.